Home › Funds › BRAIDWELL LP › GKOS

BRAIDWELL LP position in GKOS

GLAUKOS CORP · Health Care

BRAIDWELL LP reported holding 591,927 shares of GKOS (GLAUKOS CORP) in its Q2 2026 13F filing — a position valued at US$82.7M, representing 3.26% of its reported portfolio and ranking #3 among its reported holdings. BRAIDWELL LP has disclosed GKOS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)591.93K sh
Reported value held$82.73M
Portfolio Weight3.26%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's GKOS position evolved

BRAIDWELL LP first disclosed a stake in GKOS in Q3 2023 at 695,792 shares (US$52.4M). The position peaked in Q4 2025 at 921,979 shares, worth US$104.1M. Across 12 filings, BRAIDWELL LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 591,927 shares valued at US$82.7M — a reduction of -171,578 shares quarter over quarter.. Notable position changes include a 65% trim in Q4 2023 (shares rose 19% over the following quarter), a 86% increase in Q1 2024 (shares rose 26% over the following quarter), a 116% increase in Q1 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 695.79K $52.36M New
Q4 2023 242.76K $19.30M Reduce
Q1 2024 450.68K $42.49M Add
Q2 2024 496.58K $58.77M Add
Q3 2024 311.62K $40.60M Reduce
Q4 2024 288.88K $43.31M Reduce
Q1 2025 624.43K $61.46M Add
Q2 2025 603.41K $62.33M Reduce
Q3 2025 780.16K $63.62M Add
Q4 2025 921.98K $104.10M Add
Q1 2026 763.50K $82.20M Reduce
Q2 2026 591.93K $82.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GKOS and 13F data

GKOS (GLAUKOS CORP) is a Health Care company. 44 other funds we track also report a position in GKOS — the largest reported positions include SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GKOS

All GKOS fund holders →

FAQ

How long has BRAIDWELL LP held GKOS?

BRAIDWELL LP has disclosed GKOS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BRAIDWELL LP's current position in GKOS?

As of Q2 2026, BRAIDWELL LP holds 591.93K shares of GKOS (GLAUKOS CORP), valued at $82.73M, representing 3.26% of its reported portfolio and ranking #3.

Has BRAIDWELL LP been buying or selling GKOS?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in GKOS. The position peaked in Q4 2025 at 921.98K shares.

Which other funds hold GKOS?

Other major institutional holders of GKOS include SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.